New York State Cannabis Control Board Unexpectedly Cancels Meeting Discussing Homegrown Rules and Licenses
In a shocking move, the New York State Cannabis Control Board cancelled a monthly meeting that was set to discuss rules on home growing and new license applications.
New York’s cannabis industry is experiencing some challenges with moving forward. The New York State’s Cannabis Control Board cancelled their monthly meeting which was originally supposed to take place on January 24, 2024. This meeting was planning to take up and examine homegrown laws, research license applications, and new retail license applications (1). Cannabis’s rollout in the Big Apple State has been painfully slow for consumers and businesses.
“The Cannabis Control Board … has decided to postpone the meeting to finalize review of adult-use license applications currently under consideration for approval by the board,” the Office of Cannabis Management (OCM) said in their statement (1). “While we have a batch of licenses ready for approval, there are many more we want to get across the finish line to jumpstart New York’s cannabis market in 2024.”
According to their statement, license applications were being “held up by lawsuits from corporate interests,” (1). Times Union mentions one of the reasons for the slow rollout has been because of litigation (1). Previously, regulators were suspected of not offering the same equal priority under the state’s law (Marijuana Regulation and Taxation Act [MRTA]). Four service-disabled veterans filed a lawsuit against the Cannabis Control Board and Office of Cannabis Management claiming that they had not received the same equal opportunity because licenses were being given to individuals that had prior cannabis convictions (2,3). This lawsuit was settled in November 2023 (2) but that hasn’t helped ease New York’s cannabis market.
Regarding the cancelled January meeting, no information has been provided other than the need to review adult-use license applications.
Times Union explained that (1),“If there are further delays with the homegrow regulations, or issues that may extend any public comment period if they are approved in February, it could imperil the ability of anyone 21 or older to lawfully cultivate their own plants during the upcoming growing season — which will be the fourth outdoor growing season since the law that legalized the drug in New York was passed in 2021.”
New York’s rollout has been experiencing a rocky start and and it remains to be seen whether the cancelled Cannabis Control Board meeting causes further delays or frustrations to the state's cannabis industry.
References
- Lyons, B. J. NY Cannabis Board Cancels Meeting on Homegrown Pot, New Licenses https://www.timesunion.com/state/article/ny-cannabis-board-abruptly-cancels-meeting-18624400.php (accessed Jan 25, 2024).
- Colli, M. New York Settles Lawsuit Enabling More Dispensaries to Open their Doors https://www.cannabissciencetech.com/view/new-york-settles-lawsuit-enabling-more-dispensaries-to-open-their-doors (accessed Jan 24, 2024).
- McEvoy, E. New York Halts Dispensary Licenses Amid Lawsuit Over Cannabis Equity https://www.cannabissciencetech.com/view/new-york-halts-dispensary-licenses-amid-lawsuit-over-cannabis-equity (accessed Jan 24, 2024).
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
